Minor extended-spectrum β-lactamases

References

• Jacoby GA. β-lactamase nomenclature. Antimicrob. Agents Chemother.50, 1123–1129 (2006).
   PubMed Web of Science ®Google Scholar
• Livermore DM. Defining an extended-spectrum β-lactamase. Clin. Microbiol. Infect.14(Suppl. 1), 3–10 (2008).
   PubMedGoogle Scholar
• Ambler RP. The structure of β-lactamases. Philos. Trans. R. Soc. Lond. B. Biol. Sci.289, 321–331 (1980).
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob. Agents Chemother.54, 969–976 (2010).
   PubMed Web of Science ®Google Scholar
• Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection18(5), 294–298 (1990).
   PubMed Web of Science ®Google Scholar
• Bauernfeind A, Casellas JM, Goldberg M et al. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection20(3), 158–163 (1992).
   PubMed Web of Science ®Google Scholar
• Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother.48(1), 1–14 (2004).
   PubMed Web of Science ®Google Scholar
• Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill.13(47), pii19044 (2008).
   Google Scholar
• Cantón R, Coque TM. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol.9(5), 466–475 (2006).
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev.18(4), 657–686 (2005).
   PubMed Web of Science ®Google Scholar
• Peirano G, Costello M, Pitout JD. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents36(1), 19–23 (2010).
   PubMedGoogle Scholar
• Livermore DM, Canton R, Gniadkowski M et al. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother.59(2), 165–174 (2007).
   PubMed Web of Science ®Google Scholar
• Walther-Rasmussen J, Høiby N. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases. Can. J. Microbiol.50(3), 137–165 (2004).
   PubMedGoogle Scholar
• Decousser JW, Poirel L, Nordmann P. Characterization of a chromosomally encoded extended-spectrum class A β-lactamase from Kluyvera cryocrescens. Antimicrob. Agents Chemother.45(12), 3595–3598 (2001).
   PubMed Web of Science ®Google Scholar
• Humeniuk C, Arlet G, Gautier V, Grimont P, Labia R, Philippon A. β-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob. Agents Chemother.46(9), 3045–3049 (2002).
   PubMed Web of Science ®Google Scholar
• Poirel L, Kämpfer P, Nordmann P. Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrob. Agents Chemother.46(12), 4038–4040 (2002).
   PubMed Web of Science ®Google Scholar
• Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J. Antimicrob. Chemother.57(1), 14–23 (2006).
   PubMed Web of Science ®Google Scholar
• Eckert C, Gautier V, Saladin-Allard M et al. Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother.48(4), 1249–1255 (2004).
   PubMed Web of Science ®Google Scholar
• Poirel L, Decousser JW, Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) β-lactamase gene. Antimicrob. Agents Chemother.47(9), 2938–2945 (2003).
   PubMed Web of Science ®Google Scholar
• Bonnet R, Sampaio JL, Labia R et al. A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob. Agents Chemother.44(7), 936–942 (2000).
   Google Scholar
• Saladin M, Cao VT, Lambert T et al. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett.209(2), 161–168 (2002).
   PubMed Web of Science ®Google Scholar
• Oliver A, Coque TM, Alonso D et al. CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrob. Agents Chemother.49, 1567–1571 (2005).
   PubMed Web of Science ®Google Scholar
• Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis.8(3), 159–166 (2008).
   PubMed Web of Science ®Google Scholar
• Bin C, Hui W, Renyuan Z et al. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli. Diagn. Microbiol. Infect. Dis.56(4), 351–357 (2006).
   PubMed Web of Science ®Google Scholar
• Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J. Antimicrob. Chemother.50(6), 1031–1034 (2002).
   PubMed Web of Science ®Google Scholar
• Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J. Antimicrob. Chemother.50(3), 393–396 (2002).
   PubMed Web of Science ®Google Scholar
• Stürenburg E, Sobottka I, Feucht HH, Mack D, Laufs R. Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum β-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. Diagn. Microbiol. Infect. Dis.45(1), 29–34 (2003).
   PubMedGoogle Scholar
• Yu WL, Pfaller MA, Winokur PL, Jones RN. Cefepime MIC as a predictor of the extended-spectrum β-lactamase type in Klebsiella pneumoniae, Taiwan. Emerg. Infect. Dis.8(5), 522–524 (2002).
   PubMedGoogle Scholar
• Bush K, Macalintal C, Rasmussen BA, Lee VJ, Yang Y. Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob. Agents Chemother.37(4), 851–858 (1993).
   PubMed Web of Science ®Google Scholar
• Dutour C, Bonnet R, Marchandin H et al. CTX-M-1, CTX-M-3, and CTX-M-14 β-lactamases from Enterobacteriaceae isolated in France. Antimicrob. Agents Chemother.46(2), 534–537 (2002).
   PubMed Web of Science ®Google Scholar
• Bonnet R, Dutour C, Sampaio JL et al. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob. Agents Chemother.45(8), 2269–2275 (2001).
   PubMed Web of Science ®Google Scholar
• Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J. Antimicrob. Chemother.56(1), 52–59 (2005).
   PubMed Web of Science ®Google Scholar
• Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J. Antimicrob. Chemother.54(4), 735–743 (2004).
   PubMed Web of Science ®Google Scholar
• Rodríguez-Baño J, Navarro MD, Romero L et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin. Infect. Dis.43(11), 1407–1414 (2006).
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Schwaber MJ, Navon-Venezia S et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin. Infect. Dis.42(7), 925–934 (2006).
   PubMed Web of Science ®Google Scholar
• Smet A, Martel A, Persoons D et al. Characterization of extended-spectrum β-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb. Drug Resist.16(2), 129–134 (2010).
   PubMed Web of Science ®Google Scholar
• Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM. β-lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J. Antimicrob. Chemother.56(1), 115–121 (2005).
   PubMed Web of Science ®Google Scholar
• Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol.42(10), 4769–4775 (2004).
   PubMed Web of Science ®Google Scholar
• Morosini MI, García-Castillo M, Coque TM et al. Antibiotic coresistance in extended-spectrum-β-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob. Agents Chemother.50(8), 2695–2699 (2006).
   PubMed Web of Science ®Google Scholar
• Pitout JD. Infections with extended-spectrum β-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs70(3), 313–333 (2010).
   PubMed Web of Science ®Google Scholar
• Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother.43(3), 573–581 (1999).
   PubMed Web of Science ®Google Scholar
• Girlich D, Poirel L, Leelaporn A et al. Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J. Clin. Microbiol.39(1), 175–182 (2001).
   PubMedGoogle Scholar
• Poirel L, Rotimi VO, Mokaddas EM, Karim A, Nordmann P. VEB-1-like extended-spectrum β-lactamases in Pseudomonas aeruginosa, Kuwait. Emerg. Infect. Dis.7(3), 468–470 (2001).
   PubMed Web of Science ®Google Scholar
• Aubert D, Girlich D, Naas T, Nagarajan S, Nordmann P. Functional and structural characterization of the genetic environment of an extended-spectrum β-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob. Agents Chemother.48(9), 3284–3290 (2004).
   PubMedGoogle Scholar
• Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol.41(8), 3542–3547 (2003).
   PubMed Web of Science ®Google Scholar
• Carbonne A, Naas T, Blanckaert K et al. Investigation of a nosocomial outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. J. Hosp. Infect.60(1), 14–18 (2005).
   PubMed Web of Science ®Google Scholar
• Naas T, Coignard B, Carbonne A et al. VEB-1 extended-spectrum β-lactamase-producing Acinetobacter baumannii, France. Emerg. Infect. Dis.12(8), 1214–1222 (2006).
   PubMedGoogle Scholar
• Naas T, Benaoudia F, Massuard S, Nordmann P. Integron-located VEB-1 extended-spectrum β-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. J. Antimicrob. Chemother.46(5), 703–711 (2000).
   PubMedGoogle Scholar
• Chanawong A, M’Zali FH, Heritage J, Lulitanond A, Hawkey PM. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J. Antimicrob. Chemother.48(6), 839–852 (2001).
   PubMed Web of Science ®Google Scholar
• Aubert D, Naas T, Lartigue MF, Nordmann P. Novel genetic structure associated with an extended-spectrum β-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria. Antimicrob. Agents Chemother.49(8), 3590–3592 (2005).
   PubMedGoogle Scholar
• Girlich D, Naas T, Leelaporn A, Poirel L, Fennewald M, Nordmann P. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum β-lactamase in Pseudomonas aeruginosa in Thailand. Clin. Infect. Dis.34(5), 603–611 (2002).
   PubMed Web of Science ®Google Scholar
• Neuwirth C, Freby C, Ogier-Desserrey A et al. VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France. Emerg. Infect. Dis.12(11), 1737–1739 (2006).
   PubMed Web of Science ®Google Scholar
• Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum β-lactamases in Acinetobacter baumannii in Belgium. J. Antimicrob. Chemother.58(1), 178–182 (2006).
   PubMed Web of Science ®Google Scholar
• Woodford N, Zhang J, Kaufmann ME et al. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum β-lactamases in the United Kingdom. J. Antimicrob. Chemother.62(6), 1265–1268 (2008).
   PubMed Web of Science ®Google Scholar
• Strateva T, Ouzounova-Raykova V, Markova B, Todorova A, Marteva-Proevska Y, Mitov I. Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. J. Med. Microbiol.56(Pt 7), 956–963 (2007).
   PubMed Web of Science ®Google Scholar
• Pasterán F, Rapoport M, Petroni A et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob. Agents Chemother.50(9), 3222–3224 (2006).
   PubMedGoogle Scholar
• Mirsalehian A, Feizabadi M, Nakhjavani FA, Jabalameli F, Goli H, Kalantari N. Detection of VEB-1, OXA-10 and PER-1 genotypes in extended-spectrum β-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients. Burns36(1), 70–74 (2010).
   PubMed Web of Science ®Google Scholar
• Jiang X, Ni Y, Jiang Y et al. Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 β-lactamase in China. J. Clin. Microbiol.43(2), 826–831 (2005).
   PubMed Web of Science ®Google Scholar
• Kim JY, Park YJ, Kim SI, Kang MW, Lee SO, Lee KY. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum β-lactamase VEB-1 in a Korean university hospital. J. Antimicrob. Chemother.54(6), 1144–1147 (2004).
   PubMedGoogle Scholar
• Zong Z, Partridge SR, Iredell JR. A blaVEB-1 variant, blaVEB-6, associated with repeated elements in a complex genetic structure. Antimicrob. Agents Chemother.53(4), 1693–1697 (2009).
   PubMedGoogle Scholar
• Naas T, Poirel L, Karim A, Nordmann P. Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiol. Lett.176(2), 411–419 (1999).
   PubMed Web of Science ®Google Scholar
• Aubert D, Naas T, Nordmann P. IS1999 increases expression of the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa. J. Bacteriol.185(17), 5314–5319 (2003).
   PubMed Web of Science ®Google Scholar
• Nordmann P, Ronco E, Naas T, Duport C, Michel-Briand Y, Labia R. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother.37(5), 962–969 (1993).
   PubMed Web of Science ®Google Scholar
• Nordmann P, Naas T. Sequence analysis of PER-1 extended-spectrum β-lactamase from Pseudomonas aeruginosa and comparison with class A β-lactamases. Antimicrob. Agents Chemother.38(1), 104–114 (1994).
   PubMed Web of Science ®Google Scholar
• Danel F, Hall LM, Gur D, Akalin HE, Livermore DM. Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa. J. Antimicrob. Chemother.35(2), 281–294 (1995).
   PubMed Web of Science ®Google Scholar
• Vahaboglu H, Hall LM, Mulazimoglu L, Dodanli S, Yildirim I, Livermore DM. Resistance to extended-spectrum cephalosporins, caused by PER-1 β-lactamase, in Salmonella typhimurium from Istanbul, Turkey. J. Med. Microbiol.43(4), 294–299 (1995).
   PubMed Web of Science ®Google Scholar
• Vahaboglu H, Dodanli S, Eroglu C et al. Characterization of multiple-antibiotic-resistant Salmonella typhimurium stains: molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone. J. Clin. Microbiol.34(12), 2942–2946 (1996).
   PubMedGoogle Scholar
• Vahaboglu H, Oztürk R, Aygün G et al. Widespread detection of PER-1-type extended spectrum β lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother.41(10), 2265–2269 (1997).
   PubMed Web of Science ®Google Scholar
• Kolayli F, Gacar G, Karadenizli A, Sanic A, Vahaboglu H. PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp. FEMS Microbiol. Lett.249(2), 241–245 (2005).
   PubMedGoogle Scholar
• Pereira M, Perilli M, Mantengoli E et al. PER-1 extended-spectrum β-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy. Microb. Drug Resist.6(1), 85–90 (2000).
   PubMed Web of Science ®Google Scholar
• Pagani L, Migliavacca R, Pallecchi L et al. Emerging extended-spectrum β-lactamases in Proteus mirabilis. J. Clin. Microbiol.40(4), 1549–1552 (2002).
   PubMed Web of Science ®Google Scholar
• Pagani L, Mantengoli E, Migliavacca R et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase in Northern Italy. J. Clin. Microbiol.42(6), 2523–2529 (2004).
   PubMed Web of Science ®Google Scholar
• Caccamo M, Perilli M, Celenza G, Bonfiglio G, Tempera G, Amicosante G. Occurrence of extended spectrum β-lactamases among isolates of Enterobacteriaceae from urinary tract infections in southern Italy. Microb. Drug Resist.12(4), 257–264 (2006).
   PubMedGoogle Scholar
• Naas T, Kernbaum S, Allali S, Nordmann P. Multidrug-resistant Acinetobacter baumannii, Russia. Emerg. Infect.Dis.13(4), 669–671 (2007).
   PubMedGoogle Scholar
• Naas T, Nordmann P, Heidt A. Intercountry transfer of PER-1 extended-spectrum β lactamase-producing Acinetobacter baumannii from Romania. Int. J. Antimicrob. Agents.29(2), 226–228 (2007).
   PubMed Web of Science ®Google Scholar
• Litake GM, Ghole VS, Niphadkar KB, Joshi SG. PER-1-type extended-spectrum β lactamase-producing Acinetobacter baumannii clinical isolates from India. Int. J. Antimicrob. Agents34(4), 388–389 (2009).
   PubMedGoogle Scholar
• Poirel L, Cabanne L, Vahaboglu H, Nordmann P. Genetic environment and expression of the extended-spectrum β-lactamase blaPER-1 gene in Gram-negative bacteria. Antimicrob. Agents Chemother.49(5), 1708–1713 (2005).
   PubMed Web of Science ®Google Scholar
• Bauernfeind A, Stemplinger I, Jungwirth R et al. Characterization of β-lactamase gene blaPER-2, which encodes an extended-spectrum class A β-lactamase. Antimicrob. Agents Chemother.40(3), 616–620 (1996).
   PubMed Web of Science ®Google Scholar
• Vignoli R, Varela G, Mota MI et al. Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended-spectrum β-lactamases isolated from children with diarrhea in Uruguay. J. Clin. Microbiol.43(6), 2940–2943 (2005).
   PubMedGoogle Scholar
• Andres P, Petroni A, Faccone D et al. Extended-spectrum β-lactamases in Shigella flexneri from Argentina: first report of TOHO-1 outside Japan. Int. J. Antimicrob. Agents25(6), 501–507 (2005).
   PubMedGoogle Scholar
• Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. Spread of bla(CTX-M-type) and bla(PER-2) β-lactamase genes in clinical isolates from Bolivian hospitals. J. Antimicrob. Chemother.57(5), 975–978 (2006).
   PubMed Web of Science ®Google Scholar
• Girlich D, Poirel L, Nordmann P. PER-6, an extended-spectrum β-lactamase from Aeromonas allosaccharophila. Antimicrob. Agents Chemother.54(4), 1619–1622 (2010).
   PubMedGoogle Scholar
• Vahaboglu H, Coskunkan F, Tansel O et al. Clinical importance of extended-spectrum β-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J. Med. Microbiol.50(7), 642–645 (2001).
   PubMed Web of Science ®Google Scholar
• Travisano M. Evolution: towards a genetical theory of adaptation. Curr. Biol.11(11), 440–442 (2001).
   Google Scholar
• Sengupta TK, Chaudhuri K, Majumdar S, Lohia A, Chatterjee AN, Das J. Interaction of Vibrio cholerae cells with β-lactam antibiotics: emergence of resistant cells at a high frequency. Antimicrob. Agents Chemother.36(4), 788–795 (1992).
   PubMed Web of Science ®Google Scholar
• Dean AC. Adaptive drug resistance in Gram-negative bacteria. Proc. R. Soc. Med.64(5), 534–537 (1971).
   PubMedGoogle Scholar
• Luria SE, Delbrück M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics28(6), 491–511 (1943).
   PubMedGoogle Scholar